Prostatic Neoplasms: all 6,484 studies
Page 60 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00401765Phase 1
- Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate CarcinomaStatus unknownNCT00400894
- Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate CancerCompletedNCT00398281Phase 3
- Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate CancerCompletedNCT00394810Phase 2
- Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate CancerCompletedNCT00394511Phase 3
- Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the BoneCompletedNCT00392938
- Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerStatus unknownNCT00392535Not applicable
- Maintaining Bone Strength in Men With Prostate CancerTerminatedNCT00391950Phase 3
- Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerCompletedNCT00391690Phase 4
- A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate CancerTerminatedNCT00383487Phase 2
- Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate CancerTerminatedNCT00381836Phase 2/3
- A Study of ZYC300 Administered With Cyclophosphamide Pre-DosingCompletedNCT00381173Phase 1
- PSA-Activated PSA-PAH1 for Locally Recurrent Prostate CancerCompletedNCT00379561Phase 1
- Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate CancerTerminatedNCT00379119
- A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARDCompletedNCT00378690Phase 3
- Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate CancerStatus unknownNCT00376792Phase 3
- Urology Database to Evaluate Clinical Information and Improve Patient Care.CompletedNCT00376298
- Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate CancerCompletedNCT00375765Phase 4
- Investigation of Early Hormonotherapy Efficacy of Prostate CancerStatus unknownNCT00375687Not applicable
- Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate CancerCompletedNCT00375648Phase 3
- MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate CancerCompletedNCT00374049Phase 1
- Quality of Life Following Radical ProstatectomyCompletedNCT00373308
- Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate BiopsyCompletedNCT00373035
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.CompletedNCT00364455Phase 3
- Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate CancerStatus unknownNCT00363285Phase 3
- UCI 03-72 Prostate Cancer Detection by Serum Proteomic ProfilingTerminatedNCT00355758
- Prostate Cancer Screening and Dietary Heterocyclic Amines in African American MenStatus unknownNCT00354497Phase 2
- Agriculture Health StudyActive, not recruitingNCT00352924
- ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate CancerCompletedNCT00350051Phase 2
- Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNCT00349557Phase 2
- Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerStatus unknownNCT00348998Phase 2
- Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 SeedsCompletedNCT00348465
- Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate CancerCompletedNCT00345813Phase 2
- Identification of Prostate Cancer GenesCompletedNCT00342784
- An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian MalesCompletedNCT00342771
- Markers for Early Detection of Prostate CancerCompletedNCT00340717
- Analyses of Human Samples Collected in Clinical TrialsCompletedNCT00339664
- Survey of Prostate Cancer in Accra, GhanaCompletedNCT00339534
- BAY88-8223, Dose Finding Study in Patients With HRPCCompletedNCT00337155Phase 2
- Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate CancerCompletedNCT00336934Not applicable
- Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer SurgeryCompletedNCT00335634
- Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsCompletedNCT00335491Not applicable
- Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerCompletedNCT00334139Phase 4
- Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus PlaceboTerminatedNCT00332280Phase 2/3
- Sunitinib Malate With Hormonal Ablation for Patients Who Will Have ProstatectomyActive, not recruitingNCT00329043Phase 2
- Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
- 3D-Conformal Radiation vs Helical Tomotherapy in Prostate CancerStatus unknownNCT00326638Not applicable
- A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate CancerCompletedNCT00326586Phase 1
- Identification of Risk Allels for Prostate CancerWithdrawnNCT00323388
- Investigation of Protein Biomarkers of Prostate CancerWithdrawnNCT00323180
- Lycopene in Preventing Prostate Cancer in Healthy ParticipantsStatus unknownNCT00322114Not applicable
- Combination Casodex® and Iressa™ in Locally Advanced Prostate CancerCompletedNCT00319787Phase 2
- Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)CompletedNCT00318240Not applicable
- Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT00316927Phase 3
- Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPCCompletedNCT00314782Phase 1
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate CancerTerminatedNCT00313534Phase 1
- PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPCTerminatedNCT00313482Phase 2
- A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly DocetaxelTerminatedNCT00313456Phase 1
- Phase II/III Study of WST09 in Prostate Cancer After Radiation TherapyTerminatedNCT00312442Phase 2/3
- Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerCompletedNCT00310479Not applicable
- Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone TherapyCompletedNCT00309894Phase 2
- ALA and Prostate CancerStatus unknownNCT00309439Phase 2
- Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation TherapyCompletedNCT00308919Phase 2
- Study of WST09 in Prostate Cancer After Radiation: Repeat ProcedureCompletedNCT00305929Phase 2
- Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone TherapyCompletedNCT00305747Phase 1
- GM-CSF Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00305669Phase 1
- PROFIT - Prostate Fractionated Irradiation TrialCompletedNCT00304759Phase 3
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
- Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightCompletedNCT00303875Phase 2
- Prostate Adenocarcinoma TransCutaneous HormonesStatus unknownNCT00303784Phase 3
- MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)CompletedNCT00302471Phase 1
- Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate CancerStatus unknownNCT00295802Phase 2/3
- Short or Long Schemes of Antibiotic Prophylaxis for Prostate BiopsyTerminatedNCT00294749Phase 3
- ZOMETA® (Zoledronic Acid) for Prevention of Bone MetastasesTerminatedNCT00294437Phase 3
- Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate CancerStatus unknownNCT00294151Phase 3
- Casodex/Zoladex Biomarkers in Localised Prostate CancerCompletedNCT00293696Phase 4
- FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate CancerStatus unknownNCT00293670Phase 4
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2
- Robotic Laparoscopic Radical ProstatectomyCompletedNCT00292019
- PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With PrednisoloneCompletedNCT00291005Phase 2
- S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTTerminatedNCT00288106
- A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate CancerCompletedNCT00286806Phase 1/2
- Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPCCompletedNCT00286793Phase 1/2
- Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004Status unknownNCT00285675Phase 2
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerCompletedNCT00284752Phase 2
- Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerCompletedNCT00283829Phase 1/2
- FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate CancerCompletedNCT00282906Not applicable
- Docetaxel in the Treatment of Hormone Refractory Prostate CancerCompletedNCT00280098Phase 4
- Metronomic Oral Vinorelbine in Patients With Metastatic TumorsCompletedNCT00278070Phase 2
- DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])TerminatedNCT00273338Phase 3
- A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate CancerCompletedNCT00271687Phase 2
- Physicians' Health Study IICompletedNCT00270647Not applicable
- Effects of GCP on Prostate Cancer.CompletedNCT00269555Not applicable
- Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]CompletedNCT00268710Phase 2
- Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate CancerCompletedNCT00268593Phase 2
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
- Trial of Iressa in Prostate Cancer PatientsCompletedNCT00265070Phase 2
- Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases PalliationCompletedNCT00264420Phase 1